(NASDAQ: DXCM), the global leader in glucose biosensing, today announced the appointment of Jon Coleman as chief commercial officer. In this role, Mr. Coleman will assume responsibility for Dexcom’s ...

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its shares down ...

Dexcom kicks off construction on first European manufacturing site, bringing 1,000-plus jobs to Ireland Dexcom said it has “already submitted several responses to the Form 483,” and is ...